Others have investigated in vitro NASH models using strong stimuli like TGF-β and showed that simply adding this potent pro-fibrotic mediator resulted in poorer fibrotic phenotype compared to that induced by supplementing the medium with FFA13. Here, TGFB1 is linked to metabolic dysfunction-associated steatohepatitis.